Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Blackstone has stake in Emcure

July 17, 2006 | A version of this story appeared in Volume 84, Issue 29

The Blackstone Group, a private investment firm, has made its first investment in India with the purchase of a $50 million stake in Emcure Pharmaceuticals, the Pune, India-based manufacturer of active pharmaceutical ingredients and branded drug formulations. Blackstone says its relationships with managers of leading drug companies will help Emcure realize its growth strategy, which includes broadening partnerships with big pharma and making acquisitions.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.